Generic Arthrotec®

Released: 11/19/2012   By: Mike Partridge, RPh

On November 1, 2012, Greenstone commenced shipping the Authorized Generic (AG) for Pfizer’s branded product Arthrotec® (diclofenac sodium, misoprostol). For the twelve months ending May 31, 2012, Arthrotec® had total U.S. sales of approximately $130 million according to IMS Health data.
Arthrotec® is indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients in high risk of developing NSAID-induced gastric and duodenal ulcers and their complications.